Axisresearch
List of Categories
- Aerospace & Defense
- Agriculture
- Animal Nutrition & Wellness
- Automation
- Automotive
- Chemical & Materials
- Consumer Goods and Services
- Electronics
- Energy & Mining
- Financial Services & Investment Intelligence
- Food & Beverage
- Healthcare
- Heavy Industry
- Home & Property Improvement
- Information & Communications Technology
- Investment Opportunities
- Manufacturing
- NEO
- Others
- Packaging
- Retail
- Technology & Media
- Transportation & Logistics
Industrial Valves Market – Growth, Trends, and Forecast (2019 – 2024)
| Chemical & Materials | Published by: Mordor Intelligence | Market: |
| 180 pages | Published: 07-06-2019 |
- Chemical & Materials
- Mordor Intelligence
- 180 pages
- Published: 07-06-2019
Market Overview
The global industrial valves market is expected to record a CAGR of 5.33% during the forecast period of 2019and 2024. The major factor driving the market studied is the growing demand from the power and chemical industries. Stagnant industrial growth in developed countries is expected to hinder the growth of the market studied.
The oil and gas industry dominated the market in 2017, and it is expected to experience growth during the forecast period, owing to the increasing oil and gas activities across the world. Increasing demand for automatic valves is likely to act as an opportunity in the future. Asia-Pacific dominated the market across the world, with the largest consumption from countries, such as China and India.
Key Market Trends
Increasing Demand from Power Industry
In the power industry, valves are used for various applications, such as boiler startups, feed pump recirculation, steam conditioning, and turbine bypass. For instance, valves in the condensate system are used to control and regulate the additional flow required for a fluid recirculation condensate pump. Furthermore, valves are also used to control the deaerator level for the feedwater heater.
For the food water system in the power industry, valves are used for boiler feed pump recirculation and the valve plays a key role in this scenario, as it should be operated in on-off and modulating service. Additionally, in mainstream systems, the valves are used for superheaters, turbine bypass, superheater bypass, etc. A modulating valve is used for controlling pressure.
As of December 2017, 61 nuclear power plants, with 99 nuclear reactors were operating commercially in the United States. The government is planning for a number of new reactor installations, in order to increase nuclear-based power generation. Hence, the country is expected to witness four new units, which are expected to come online by 2021.
Additionally, the government’s focus on increasing the capacity additions of power plants across the country is the factor that is boosting the demand for cooling water treatment chemicals. Such aforementioned factors are boosting the demand for valves in the power industry.
Asia-Pacific Region to Dominate the Market
The Asia-Pacific region dominated the global market share in 2017. With growing oil and gas industrial activities and the increasing need for water treatment in countries, such as China, India, and Japan, the usage of industrial valves is increasing in the region.
The consumption of industrial valves is high in oil and gas, and downstream production has increased in the country. This is further increasing the production capacities of petrochemicals, thus augmenting the consumption of industrial valves in the country. Chemical plants are another prominent end-user industry in China. Many major companies in the market have their chemical plants in China. These companies increased their production capacities, in order to increase the consumption of industrial valves.
The other major industry in the country is the water treatment facility, which is used in different industries. The growing fuel demand is augmenting the demand to increase the refining capacity, due to increased sales of passenger cars, replacement of LPG as a cooking fuel, increasing urbanization, along with the demand for infrastructure and consumer goods. The aforementioned factors, coupled with government support, are contributing to the increasing demand for industrial valves consumption in the region during the forecast period.
Competitive Landscape
The global industrial valves market is highly fragmented, with the top 10 players accounting for 15% of the total market share. The major companies include Schlumberger Limited (previously Cameron International), Emerson Electric Co., Flowserve Corporation, IMI PLC, and Crane Co.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1. Introduction
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1 Market Drivers
4.1.1 Growing Demand from the Power Industry
4.1.2 Increase in Demand for Desalination Activity
4.1.3 Increase in Demand from the Chemical Industry
4.2 Market Restraints
4.2.1 Stagnant Industrial Growth in Developed Countries
4.3 Value Chain / Supply Chain Analysis
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. Market Segmentation
5.1 Type
5.1.1 Butterfly Valve
5.1.2 Ball Valve
5.1.3 Globe Valve
5.1.4 Gate Valve
5.1.5 Plug Valve
5.1.6 Other Types
5.2 Product
5.2.1 Quarter-turn Valve
5.2.2 Multi-turn Valve
5.2.3 Other Products (Control Valves)
5.3 Application
5.3.1 Power
5.3.2 Water and Wastewater Management (Including Desalination)
5.3.3 Chemicals
5.3.4 Oil and Gas
5.3.4.1 Upstream
5.3.4.2 Mid-stream
5.3.4.3 Downstream
5.3.5 Food Processing
5.3.6 Other Applications
5.4 Geography
5.4.1 Asia-Pacific
5.4.1.1 China
5.4.1.2 India
5.4.1.3 Japan
5.4.1.4 South Korea
5.4.1.5 Australia & New Zealand
5.4.1.6 Rest of Asia-Pacific
5.4.2 North America
5.4.2.1 United States
5.4.2.2 Canada
5.4.2.3 Mexico
5.4.2.4 Rest of North America
5.4.3 Europe
5.4.3.1 Germany
5.4.3.2 United Kingdom
5.4.3.3 Italy
5.4.3.4 France
5.4.3.5 Russia
5.4.3.6 Rest of Europe
5.4.4 South America
5.4.4.1 Brazil
5.4.4.2 Argentina
5.4.4.3 Rest of South America
5.4.5 Middle East & Africa
5.4.5.1 Saudi Arabia
5.4.5.2 South Africa
5.4.5.3 Rest of Middle East & Africa
6. Competitive Landscape
6.1 Mergers and Acquisitions, Joint Ventures, Collaborations, and Agreements
6.2 Market Share Analysis**
6.3 Strategies Adopted by Leading Players
6.4 Company Profiles
6.4.1 Alfa Laval
6.4.2 AVK Holding AS
6.4.3 Broer Group
6.4.4 CIRCOR International Inc.
6.4.5 Crane Co.
6.4.6 Curtiss-Wright Corporation
6.4.7 Danfoss AS
6.4.8 Emerson Electric Co.
6.4.9 Georg Fischer Ltd
6.4.10 Flowserve Corporation
6.4.11 General Electric (Baker Hughes)
6.4.12 Hitachi Metals Ltd
6.4.13 Honeywell International Inc.
6.4.14 IMI PLC
6.4.15 ITT Inc.
6.4.16 KITZ Corporation
6.4.17 Mueller Water Products Inc.
6.4.18 NIBCO INC.
6.4.19 Okano Valve Mfg. Co. Ltd
6.4.20 Saint-Gobain
6.4.21 Schlumberger Limited
6.4.22 TechnipFMC PLC
6.4.23 The Weir Group PLC
6.4.24 Valvitalia SpA
6.4.25 Xylem
6.4.26 DUNAN
7. Market Opportunities and Future Trends
7.1 Increase in Demand for Automatic Valves
Market Segmentation
- Type
Butterfly Valve
Ball Valve
Globe Valve
Gate Valve
Plug Valve
Other Types
Product
Quarter-turn Valve
Multi-turn Valve
Other Products (Control Valves)
Application
Power
Water and Wastewater Management (Including Desalination)
Chemicals
Oil and Gas
Upstream
Mid-stream
Downstream
Food Processing
Other Applications - Geography
Asia-Pacific
China
India
Japan
South Korea
Australia & New Zealand
Rest of Asia-Pacific
North America
5.4.2.1 United States
5.4.2.2 Canada
5.4.2.3 Mexico
5.4.2.4 Rest of North America
Europe
5.4.3.1 Germany
5.4.3.2 United Kingdom
5.4.3.3 Italy
5.4.3.4 France
5.4.3.5 Russia
5.4.3.6 Rest of Europe
South America
5.4.4.1 Brazil
5.4.4.2 Argentina
5.4.4.3 Rest of South America - Middle East & Africa
5.4.5.1 Saudi Arabia
5.4.5.2 South Africa
5.4.5.3 Rest of Middle East & Africa
Anti-obesity Drugs Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 118 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 118 pages
- Published: 07-06-2019
Market Overview
The anti-obesity drugs market is growing steadily with the gradual growth in the number of approvals from the US FDA and Europe EMA. North America, especially the United States, dominates this market, due to better healthcare services and high expenditure, followed by Europe. Till 2012, Xenical (orlistat) and generic phentermine were among the only approved drugs. However, the period between 2012 and 2016 saw high growth in the number of major pharmaceutical companies investing largely on clinical trials.
However, there are still very fewer drugs in the late stage of development. Owing to the less success rate and withdrawal among the centrally acting drugs, several of the major companies have considered the development of anti-obesity drugs as prohibitively risky and shifted the companies’ inclination toward broadening the scope of a diabetic portfolio into obesity. Since several companies have developed a strong relationship between Type 2 diabetes and obesity, it is often considered to be a low-risk strategy and minor investments in the R&D for potential anti-obesity drugs. Currently, the market is gradually growing its authority in the developing regions with the gradual approval of drugs, globally. However, it holds great potential with the aforementioned advantages, as several companies are targeting dual therapy mode for the treatment of obesity.
The Scope of the Report
An ideal anti-obesity drug would help in reducing sustained weight with minimal side effects. Mechanisms that control energy balance have considerable built-in redundancy, overlap with other physiological functions, and are subjected to social and psychological factors that restrict the effectiveness of pharmacological interventions. The anti-obesity drug market is segmented on the basis of the mechanism of action (peripherally acting and centrally acting anti-obesity drugs) and drug type (prescription and OTC drugs).
Key Market Trends
OTC Drugs Segment is Expected to Exhibit Fastest Growth Rate over the Forecast Period
In the present scenario, the weight problem is a major concern, globally. The rising intake of junk food/fast food is resulting in declining healthiness worldwide. As mentioned earlier, obesity is one of the most prevalent problems faced by people of this century. According to WHO, in 2016, more than 1.9 billion adults, ranging between 18 years and older, were overweight. Out of the aforementioned numbers, over 650 million were obese. With intentions to offer weight loss solutions, the companies have developed a number of weight loss products, of which a considerable proportion are OTC drugs.
In most countries, Orlistat is marketed as a prescription drug under the trade name Xenical, by Roche, and it is sold as an OTC drug under the trade name Alli, by GlaxoSmithKline, in the United Kingdom and the United States. Currently, the number of OTC drugs approved in the market is very less. However, the cost-effectiveness and ease of availability of OTC products are expected to propel the growth of the market.
North America Captured the Largest Market Share and is Expected to Retain its Dominance
North America dominated the global anti-obesity drugs market, with the United States accounting for the major contributor to the market. The primary factors driving the growth of the market studied are an increase in obese population and high healthcare spending. In the past few decades, several anti-obesity drugs are withdrawn from the market, due to reported and documented adverse effects. After years of interruption, the US Food and Drug Administration (FDA) has recently approved multiple new anti-obesity drugs. Majority of these medications are administered orally, and only one is administered subcutaneously. According to the data published by the Centers for Disease Control and Prevention (CDC), the prevalence of obesity was 39.8% and affected about 93.3 million US adults in 2015-2016, hence propelling the anti-obesity drugs market.
Competitive Landscape
The presence of major market players, such as GlaxoSmithKline, Novo Nordisk, Pfizer, F Hoffmann-La Roche, and Bayer AG, is, in turn, increasing the overall competitive rivalry of the market. Large organizations rely heavily on advertising expenses and branding strategies, collaborating with successful personality, initiative, or programs at the national levels, which promote their product, and thus are recognized earlier than other brands in the market. With the high prevalence rate of the disease, the intensity of competitive rivalry is moderate to high.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1. Introduction
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increase in Prevalence of Obesity
4.2.2 Sedentary Lifestyle
4.3 Market Restraints
4.3.1 Availability of Alternative Treatment Options
4.3.2 Side Effects of Drugs
4.3.3 High Drug Development Costs
4.4 Industry Attractiveness- Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. Market Segmentation
5.1 Mechanism of Action
5.1.1 Peripherally Acting Anti-obesity Drugs
5.1.2 Centrally Acting Anti-obesity Drugs
5.2 Drug Type
5.2.1 Prescription Drugs
5.2.2 OTC drugs
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 United Kingdom
5.3.2.2 Germany
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6. Competitive Landscape
6.1 Company Profiles
6.1.1 Arena Pharmaceuticals
6.1.2 GlaxoSmithKline
6.1.3 Nalpropion Pharmaceuticals Inc.
6.1.4 F Hoffmann-La Roche
6.1.5 Vivus
6.1.6 Bayer AG
6.1.7 Novo Nordisk
6.1.8 Pfizer
6.1.9 Eisai
7. Market Opportunities And Future Trends
Market Segmentation
- Mechanism of Action
Peripherally Acting Anti-obesity Drugs
Centrally Acting Anti-obesity Drugs
Drug Type
Prescription Drugs
OTC drugs
Geography
North America
United States
Canada
Mexico
Europe
United Kingdom
Germany
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific - Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Structural Insulated Panels Market – Growth, Trends, And Forecast (2019 – 2024)
| Chemical & Materials | Published by: Mordor Intelligence | Market: |
| 120 pages | Published: 07-06-2019 |
- Chemical & Materials
- Mordor Intelligence
- 120 pages
- Published: 07-06-2019
Market Overview
The global structural insulated panel market is expected to register healthy growth, by 2024, at an estimated CAGR of 6.13% over 2019-2024.
The major factors driving the market studied are the increasing demand from the construction sector and increasing cold storage applications. Advancements in building technologies such as modular construction techniques are expected to hinder the growth of the market studied.
In 2018, the building wall segment is expected to dominate the market and expand at the fastest CAGR of 6.39% during the forecast period. This is due to the robust demand from the residential sector. In 2017, North America dominated the market, holding a share of almost 37%, and is expected to register a CAGR of 6.21% during the forecast period. This growth is primarily due to rising construction activities in Canada and Mexico.
Key Market Trends
Increasing Demand for Building Walls
Structural insulated wall panels are generally available in thicknesses of 4-1/2 inches and 6-1/2 inches. Manufacturing of curved wall panels are possible and it is often more practical to use stud framing for non-orthogonal geometries.
The whole wall R-value of a wall assembly is currently the best and the most followed method of quantifying the total thermal performance. The whole wall R-value takes the resistance of heat flown through an opaque cross-sectional area of the insulation and structure into the account while the total loss of energy at the interfaces of the wall with the roof and floor are accounted.
The whole wall R-value of a 4-inch structural insulated wall panel is 14, whereas for a 2×4 wall is less than 10. The whole wall R-value of a 2×6 wall is between 11 and 13.7 depending on the quality of the installation of batt insulation. The elimination of thermal bridging and a more airtight envelope contributes to the higher whole wall R-value of structural insulated wall panels, compared to the conventional metal and wood stud walls. The total volume of the panels used as structural insulated wall panels is much higher, compared to the volume of the panels used as structural insulated roof panels.
North America Region to Dominate the Market
North America region dominated the global market share in 2017. The construction industry in the United States has not been the same in 2017 as it was in the past three years. An increase has been observed in private construction spending over the years. The residential and non-residential construction in 2017 has increased significantly compared to the previous years and is likely to grow in 2018.
Competitive Landscape
The global structural insulated panels market is a highly fragmented market with no major player accounting for a prominent share in the global market. Most of the market leaders are forward integrated, i.e., they produce structural insulated panels along with providing installations and maintenance services. Premier Building Systems is the leading manufacturer of structural insulated panels in the North America region.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1. Introduction
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1 Drivers
4.1.1 Increasing Demand from the Construction Sector
4.1.2 Increasing Cold Storage Applications
4.2 Restraints
4.2.1 Advancements in Building Technologies such as Modular Construction Techniques
4.3 Industry Value-Chain Analysis
4.4 Porters 5 Force Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Consumers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products and Services
4.4.5 Degree of Competition
5. Market Segmentation
5.1 Product
5.1.1 EPS (Expanded Polystyrene) Panel
5.1.2 Rigid Polyurethane (PUR) and Rigid Polyisocyanurate (PIR) Panel
5.1.3 Glass Wool Panel
5.1.4 Other Products (Extruded Polystyrene Foam)
5.2 Application
5.2.1 Building Wall
5.2.2 Building Roof
5.2.3 Cold Storage
5.3 Geography
5.3.1 Asia-Pacific
5.3.1.1 China
5.3.1.2 India
5.3.1.3 Japan
5.3.1.4 South Korea
5.3.1.5 Rest of Asia-Pacific
5.3.2 North America
5.3.2.1 United States
5.3.2.2 Canada
5.3.2.3 Mexico
5.3.2.4 Rest of North America
5.3.3 Europe
5.3.3.1 Germany
5.3.3.2 United Kingdom
5.3.3.3 Italy
5.3.3.4 France
5.3.3.5 Russia
5.3.3.6 Rest of Europe
5.3.4 South America
5.3.4.1 Brazil
5.3.4.2 Argentina
5.3.4.3 Rest of South America
5.3.5 Middle East & Africa
5.3.5.1 Saudi Arabia
5.3.5.2 South Africa
5.3.5.3 Rest of Middle East & Africa
6. Competitive Landscape
6.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
6.2 Market Share Analysis**
6.3 Strategies Adopted by Leading Players
6.4 Company Profiles
6.4.1 Alubel SpA
6.4.2 ArcelorMittal
6.4.3 BALEX-METAL
6.4.4 DANA Group of Companies
6.4.5 Isopan (Manni Group SpA)
6.4.6 Italpannelli SRL
6.4.7 Jiangsu Jingxue Insulation Technology Co. Ltd
6.4.8 Kingspan Group
6.4.9 Marcegaglia SpA
6.4.10 Metecno
6.4.11 Multicolor Steels (India) Pvt Ltd
6.4.12 NCI Building Systems
6.4.13 Nucor Building Systems
6.4.14 Owens Corning
6.4.15 PFB Corporation
6.4.16 Premier Building Systems
6.4.17 Rautaruukki Corporation
6.4.18 Tata Steel Europe Limited
6.4.19 Zamil Steel Pre-Engineered Buildings Co. Ltd
7. Market Opportunities and Future Trends
7.1 Increase in Demand from Emerging Economies
Market Segmentation
- Product
EPS (Expanded Polystyrene) Panel
Rigid Polyurethane (PUR) and Rigid Polyisocyanurate (PIR) Panel
Glass Wool Panel
Other Products (Extruded Polystyrene Foam)
Application
Building Wall
Building Roof
Cold Storage
Geography
Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
North America
United States
Canada
Mexico
Rest of North America - Europe
Germany
United Kingdom
Italy
France
Russia
Rest of Europe
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
UAE In-Vitro Diagnostics Market – Growth, Trends & Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 85 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 85 pages
- Published: 07-06-2019
Market Overview
The growth of the UAE IVD market can be attributed to the high prevalence of chronic and infectious diseases. Chronic diseases are a growing global challenge, and according to WHO estimates, account for approximately 60% of all deaths, worldwide. In addition, WHO states that chronic diseases, such as cancer, cardiovascular diseases, diabetes, and chronic respiratory diseases are responsible for 12%, 40%, 5%, and 5% of mortality in the United Arab Emirates. The current market is also growing due to the use of advanced technologies in the IVD market. There has been a paradigm shift from traditional diagnostics to a new generation diagnostics, that works at the gene level. This was made possible by the inclusion of advanced technologies, such as genetic testing, molecular diagnostics, polymerase chain reaction (PCR), and next-generation sequencing (NGS).
Scope of the Report
In-vitro diagnostics involves medical devices and consumables that are utilized to perform in-vitro tests on various biological samples. They are used for the diagnosis of various medical conditions, such as chronic diseases.
Key Market Trends
Reagents Segment holds the Largest Market Share in the Product Type Segment
Reagents capture the largest market share and are expected to exhibit the fastest growth rate over the forecast period, owing to repeat purchase and increasing demand. The reagent segment of the market studied includes chemical, biological, or immunological components, solutions, and preparations intended by the manufacturer to be used during the in-vitro diagnostic process. Given the high cost of many diagnostic platforms, it is common for manufacturers to lease equipment instead of selling technology outright to end users. In these arrangements, the lease is tied to contracts to purchase associated reagents or assay kits for the equipment over the life of the contract.
Many diagnostic companies have in excess of 75% of sales from consumables, such as assays and reagents, and such agreements guarantee the generation of cyclic revenues associated with the sale of reagents and other consumables. Reagent usage for IVD kits often carry high costs,;hence, the availability of immunodiagnostic services in developing countries is often limited by the high cost of imported kits. Many developing countries have established local immunoassay reagent programs to manufacture low-cost, high-quality immunoassay reagents. Kits from these projects are now beginning to become available and are likely to fuel the market expansion.
Competitive Landscape
The major market players in the UAE in-vitro diagnostics market are bioMérieux, Qiagen, Abbott Laboratories, and Roche Diagnostics, and Siemens among others. The competition among manufacturers is increasing, with the increasing number of companies. Small manufacturers represent an unorganized market due to the lower prices of their products.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1. Introduction
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1 Market Overview
4.2 Market Drivers
4.2.1 High Prevalence of Chronic Diseases
4.2.2 Increasing Use of Point-of-care (POC) Diagnostics
4.2.3 Technological Advancements
4.2.4 Increasing Awareness and Acceptance of Personalized Medicine and Companion Diagnostics
4.3 Market Restraints
4.3.1 Stringent Regulations
4.3.2 Cumbersome Reimbursement Procedures
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. Market Segmentation
5.1 By Technique
5.1.1 Immunochemistry
5.1.2 POC Diagnostics
5.1.3 Molecular Diagnostics
5.1.4 Hematology
5.1.5 Tissue Diagnostics
5.1.6 Microbiology
5.1.7 Self-blood Glucose Monitoring
5.1.8 Other Techniques
5.2 By Product
5.2.1 Instrument
5.2.2 Reagent
5.2.3 Data Management System
5.3 By Usablity
5.3.1 Disposable IVD Devices
5.3.2 Reusable IVD Devices
5.4 By Application
5.4.1 Infectious Disease
5.4.2 Diabetes
5.4.3 Cancer/Oncology
5.4.4 Cardiology
5.4.5 Autoimmune Disease
5.4.6 Nephrology
5.4.7 Drug Testing
5.4.8 HIV/AIDS
5.4.9 Other Applications
5.5 End User
5.5.1 Laboratory & Academia
5.5.2 Hospitals and POC Testing Centers
5.5.3 Other End Users
6. Competitive Landscape
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Becton, Dickinson and Company
6.1.3 bioMérieux
6.1.4 Bio-Rad Laboratories, Inc.
6.1.5 Danaher Corporation
6.1.6 Qiagen
6.1.7 F. Hoffmann-La Roche Ltd
6.1.8 Siemens Healthcare GmBH
6.1.9 Sysmex Corporation
6.1.10 Thermo Fisher Scientific
7. Market Opportunities and Future Trends
Market Segmentation
- By Technique
Immunochemistry
POC Diagnostics
Molecular Diagnostics
Hematology
Tissue Diagnostics
Microbiology
Self-blood Glucose Monitoring
Other Techniques
By Product
Instrument
Reagent
Data Management System
By Usablity
Disposable IVD Devices
Reusable IVD Devices
By Application
Infectious Disease
Diabetes
Cancer/Oncology
Cardiology
Autoimmune Disease
Nephrology
Drug Testing
HIV/AIDS
Other Applications - End User
Laboratory & Academia
Hospitals and POC Testing Centers
Other End Users
Alpha Emitter Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 115 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 115 pages
- Published: 07-06-2019
Market Overview
The global alpha emitter market was valued at USD 506.5 million in 2018, and it is estimated to be valued at USD 3302.99 million by 2024 while witnessing a CAGR of 36.69% over the forecast period of 2019-2024. Certain factors that are driving the market growth include increased awareness about the potential benefits of targeted alpha therapy, and the growing number of patients with cardiac and cancer ailments.
Targeted anticancer or alpha therapy (TAT) is gaining popularity with the increasing prevalence of cancer and cardiovascular diseases. Consumers are now increasingly aware of the potential benefits of targeted therapies to cure such ailments.
Furthermore, radioimmunotherapy with short-ranged and high-efficiency α-particles is a striking and promising treatment approach. α-particles have an advantage in targeted therapy because of their exceptionally high cell-killing ability. However, regulatory requirements pose a hurdle to translational research and clinical investigations. For instance, in the United States, all pharmacologic agents, including diagnostic radiopharmaceuticals and radiotherapeutics, undergo regulatory oversight by the FDA. Similarly, radiopharmaceuticals face additional scrutiny and undergo unique regulatory and approval pathways, across the world.
Scope of the Report
In therapeutic radiopharmaceuticals, radionuclides with alpha emitters play a significant role in treating cancers. Properties of alpha emitters have led to exert profound differences between this field and other fields of nuclear medicine. Due to their short range and high LET (deposit energy in a unit length of their pathway), alpha particles have remarkably been considered into medical research.
Key Market Trends
Medical Application in Ovarian Cancer is Expected to Observe the Highest Growth Rate over the Forecast Period
The ovarian cancer segment in the alpha emitter market is expected to witness the highest CAGR of 35.63% during the forecast period.
The growth rate is attributed to an increasing number of new diagnosis cases. As per the estimates of the American Cancer Society, in 2018, around 22,240 women were expected to receive a new diagnosis of ovarian cancer, and about 14,070 women would die from ovarian cancer.
Ovarian cancer uses radioimmunotherapy as locally injected adjuvant therapy. Trials have evaluated the practice of complete abdominal or moving-strip external-beam radiotherapy (EBRT) or non-specific i.p. radiotherapy, with colloid preparations of Au-198 or P-32 as adjuvant therapies.
Moreover, the adoption of targeted alpha therapy with higher LET and shorter wavelengths has been promising in the treatment process. This trend is expected to gain traction in the near future. In addition, a recent Phase I clinical trial involving At-211-MX35 F (ab′) showed significant efficacy, as therapeutic doses reached their targets in patients with ovarian cancer.
North America Dominates the Market and is Expected to do Same in the Forecast Period
North America currently dominates the alpha emitter market, and it is expected to continue its stronghold for a few more years. This region is expected to increase its market share in the future, owing to the fact that the increase in cardiac and neurological chronic diseases is the major driving factor for the market growth in the region. For instance, 223RaCl2 (Xofigo) is the first alpha-emitting radioisotope to gain registration in the United States for palliative therapy of prostate cancer bone metastases through indirect physiological targeting.
Moreover, according to the National Cancer Institute, the number of new cases of melanoma was 21.8 per 100,000 men and women, per year. Similarly, the rising prevalence of cancer is making it imperative for the healthcare professionals across Canada to increase the radiotherapy utilization for cancer treatment. This is directly affecting the growth of the alpha emitter market in the country.
Competitive Landscape
The global alpha emitter market is less competitive and consists of very few major players. Companies, like IBA Radiopharma Solutions, Bayer AG, Alpha Tau Medical Ltd, Actinium Pharmaceutical Inc., Telix Pharmaceuticals Ltd, RadioMedix Inc., and Fusion Pharmaceuticals hold the substantial market share in the global alpha emitter market.
A number of developments have been taking place in the market over recent years.
For example, in November 2017, Actinium Pharmaceuticals launched the AWE Program, aka Actinium Warhead Enabling Program, to enable collaborations based on its Actinium-225 Technology Platform. Whereas, in November 2017, Alpha Tau Medical entered a collaboration with IRST Italy to treat its first cancer patients. This is significant progress toward international expansion. This is also expected to enable the availability of Alpha DaRT radiotherapy all across Europe, Asia, as well as the United States.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1. Introduction
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increased Awareness About the Potential Benefits of Targeted Alpha Therapy
4.2.2 Increasing Number of Patients with Cardiac and Cancer Ailments
4.3 Market Restraints
4.3.1 Short Half-life of Radiopharmaceuticals
4.3.2 Stringent Regulatory Framework and Reimbursement Issues
4.3.3 Need for High Capital Investment
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. Market Segmentation
5.1 Type of Radionuclide
5.1.1 Terbium (Tb-149)
5.1.2 Astatine (At-211)
5.1.3 Bismuth (Bi-212)
5.1.4 Actinium (Ac-225)
5.1.5 Radium (Ra-223)
5.1.6 Lead (Pb-212)
5.1.7 Bismuth (Bi -213)
5.2 Medical Application
5.2.1 Glioma
5.2.2 Melanoma
5.2.3 Pancreatic Cancer
5.2.4 Ovarian Cancer
5.2.5 Thyroid
5.2.6 Bone Metastasis
5.2.7 Lymphoma
5.2.8 Endocrine Tumors
5.2.9 Other Medical Applications
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6. Competitive Landscape
6.1 Company Profiles
6.1.1 Actinium Pharmaceutical Inc.
6.1.2 Alpha Tau Medical Ltd
6.1.3 Bayer AG
6.1.4 Fusion Pharmaceuticals
6.1.5 IBA Radiopharma Solutions
6.1.6 RadioMedix Inc.
6.1.7 Telix Pharmaceuticals Ltd
7. Market Opportunities and Future Trends
Market Segmentation
- Type of Radionuclide
Terbium (Tb-149)
Astatine (At-211)
Bismuth (Bi-212)
Actinium (Ac-225)
Radium (Ra-223)
Lead (Pb-212)
Bismuth (Bi -213)
Medical Application
Glioma
Melanoma
Pancreatic Cancer
Ovarian Cancer
Thyroid
Bone Metastasis
Lymphoma
Endocrine Tumors
Other Medical Applications
Geography
North America
United States
Canada
Mexico - Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
MEXICO RETAIL SECTOR – GROWTH, TRENDS, AND FORECAST (2019 – 2024)
| NEO | Published by: Mordor Intelligence | Market: |
| 159 pages | Published: 07-06-2019 |
- NEO
- Mordor Intelligence
- 159 pages
- Published: 07-06-2019
Market Overview
The Mexican retail sector is projected to witness a CAGR of 6.7% by 2024. The market is segmented by product category, distribution channel, and market dynamics. Mexico stands out as one of the key markets, and is doing so through sustained evolution and slow but steady growth in many dimensions.
The retail and consumer sector is one industry that has the potential to exceed Mexico’s average national future growth. This will be driven by a combination of economic and socio-demographic trends, offerings, and business models to appeal to Mexican consumers.
The retail and consumer sector reflects the opportunities emerging from the duality of the Mexican economy, better than any other sector. Modern format retail stores and multinational franchises, such as Walmart and Starbucks, are constantly growing and developing, alongside the resilient traditional changarros’ and adapted concepts, such as OXXO and Farmacias Similares.
Scope of the Report
A complete background analysis of the Mexican retail sector, which includes an assessment of the parental market, emerging trends by segments and regional markets, significant changes in market dynamics, and market overview, is covered in the report.
Key Market Trends
High Disposable Income and High Retail Growth
Despite a complex social situation in which criminal undertones color everyday life, Mexico’s recent economic upturn has generated a sense of optimism among consumers. With disposable incomes rising, Mexicans are more willing to invest in themselves, be it on clothing, health, or beauty products. Mexican consumers are spending most of their money across a smaller number of categories, and are looking to turn their aspirations of success into reality by spending more on beauty and personal care products. In Mexican culture, well-known, established brands are seen as reliable and trustworthy.
Many in-country retailers are set to continue their expansion, targeting smaller cities with the potential to grow, due to a lower presence of retail outlets per inhabitant. From 2012-2016, the average growth of traditional trade has been increasing from 5%-10%, representing a higher percentage of sales and a growing trend in the retailing industry. Mexico has a fragmented and competitive environment due to the relevance of traditional formats and small independent retailers across all channels. Leading players are set to increase their geographical footprints throughout the country, by increasing the number of operating outlets.
High Growth of Apparel and Accessories in Mexico
The Mexican fashion industry reached its highest production levels by the mid of 2018, even under challenging circumstances, with 50 of the most internationally renowned brands selling in the country. The challenge is to maintain or expand this production. Revenue in the apparel market is expected to grow annually at 7.1% by 2024.
In the apparels sector, the women’s and girls’ apparels segment holds the largest share.
The expansion of the middle class, with young working consumers who follow trends and growth of cities, is contributing to the increasing number of shopping centers. Mexicans like to spend their free time at shopping centers, regardless of their social status. Over the last couple of years of the review period, the apparel and footwear industry saw the entrance of international brands. Fast-fashion stood to be a critical factor behind this change. E-commerce in Mexico is booming, bringing new growth opportunities for the consumer goods and retail industries.
Competitive Landscape
The report covers major international players operating in the Mexican retail sector. In terms of market share, few of the major players currently dominate the market. However, with technological advancement and product innovation, midsize to smaller companies are increasing their market presence, by securing new contracts and by tapping new markets.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1. Introduction
1.1 Key Deliverables of the Study
1.2 Study Assumptions
1.3 Research Methodology
2. Scope of Study
3. Market Insights
3.1 Market Overview
3.2 Customer Behavior Analysis
3.3 Industry Attractiveness – Porter’s Five Forces Analysis
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Industry Value Chain Analysis
5. Technology Snapshot
6. Market Segmentation
6.1 By Product
6.1.1 Food and Beverage and Tobacco Products
6.1.2 Personal Care and Household
6.1.3 Apparel, Footwear, and Accessories
6.1.4 Furniture, Toys, and Hobby
6.1.5 Industrial and Automotive
6.1.6 Electronic and Household Appliances
6.1.7 Pharmaceuticals, Luxury Goods, and Other Products
7. Insights on Distribution Channels in Retail Trade
7.1 Hypermarkets, Supermarkets, and Convenience Stores
7.2 Specialty Stores
7.3 Department Stores
7.4 E- commerce
7.5 Other Distribution Channels
8. Company Profiles
8.1 Organization Soriana SA de
8.2 FEMSA Comercio SA
8.3 Coppel SA de CV
8.4 El Puerto de Liverpool
8.5 Walmart International
8.6 El Palacio de Hierro
8.7 Superama
8.8 Sears Operadora Mexico SA De CV
8.9 Auchan
8.10 Carrefour
9. Investment Analysis on the Mexico Retail Sector
10. Future of the Mexico Retail Sector
By Product
- Food and Beverage and Tobacco Products
Personal Care and Household
Apparel, Footwear, and Accessories
Furniture, Toys, and Hobby
Industrial and Automotive
Electronic and Household Appliances
Pharmaceuticals, Luxury Goods, and Other Products